Tenax Therapeutics Stock Cash Flow From Operations
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Tenax Therapeutics' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Tenax Therapeutics Company Cash Flow From Operations Analysis
Tenax Therapeutics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Tenax Therapeutics Cash Flow From Operations | (14.81 M) |
Most of Tenax Therapeutics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tenax Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Tenax Therapeutics has (14.81 Million) in Cash Flow From Operations. This is 102.81% lower than that of the Biotechnology sector and 123.69% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 101.52% higher than that of the company.
Tenax Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tenax Therapeutics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tenax Therapeutics could also be used in its relative valuation, which is a method of valuing Tenax Therapeutics by comparing valuation metrics of similar companies.Tenax Therapeutics is currently under evaluation in cash flow from operations category among its peers.
Tenax Fundamentals
| Return On Equity | -0.56 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 23.29 M | ||||
| Shares Outstanding | 4.56 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 99.80 % | ||||
| Number Of Shares Shorted | 762.35 K | ||||
| Price To Earning | (0.35) X | ||||
| Price To Book | 0.31 X | ||||
| EBITDA | (17.58 M) | ||||
| Net Income | (17.6 M) | ||||
| Cash And Equivalents | 7.23 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 4.69 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 2.61 X | ||||
| Cash Flow From Operations | (14.81 M) | ||||
| Short Ratio | 7.57 X | ||||
| Earnings Per Share | 2.94 X | ||||
| Target Price | 20.0 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 32.39 M | ||||
| Total Asset | 96.69 M | ||||
| Retained Earnings | (314.86 M) | ||||
| Working Capital | 91.99 M | ||||
| Current Asset | 21.86 M | ||||
| Current Liabilities | 3.56 M | ||||
| Net Asset | 96.69 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Tools for Tenax Stock
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |